Literature DB >> 9840141

Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.

L Shen1, J Fang, D Qiu, T Zhang, J Yang, S Chen, S Xiao.   

Abstract

BACKGROUND/AIMS: This study was undertaken to obtain information at the molecular level on the possible mechanism of human hepatocarcinogenesis and also to provide a clue for further study.
METHODOLOGY: We examined the methylation patterns of c-myc and c-N-ras oncogenes, which are most closely related to HCC, by using the Southern blot technique and HpaII/MspI restriction enzymes. In addition, we measured the level of global DNA methylation in cancerous and paracancerous tissues of HCC by incubating DNA with 3H-S-adenosylmethionine (3H-SAM) in the presence of methylase. The measured global level of DNA methylation was compared with pathological changes of the liver. The methylation patterns of oncogenes as well as the levels of global DNA methylation were compared with pathological changes.
RESULTS: The results showed that the hypomethylation rates of c-myc and c-N-ras oncogenes were 30% and 61% respectively in human hepatocellular carcinoma, coinciding with a decreased level of global DNA methylation. DNA hypomethylation was highly significant in cases with a tendency of tumor infiltration or metastasis.
CONCLUSIONS: It is concluded that abnormal DNA methylation plays an important role in the process of hepatocellular carcinogenesis. DNA methylation level is closely correlated with the biological characteristic of liver cancer, the lower the level of DNA methylation, the stronger the infiltration and metastatic capacity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840141

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  16 in total

Review 1.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.

Authors:  Yujin Hoshida; Sara Toffanin; Anja Lachenmayer; Augusto Villanueva; Beatriz Minguez; Josep M Llovet
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

3.  Benzo[a]pyrene decreases global and gene specific DNA methylation during zebrafish development.

Authors:  Xiefan Fang; Cammi Thornton; Brian E Scheffler; Kristine L Willett
Journal:  Environ Toxicol Pharmacol       Date:  2013-02-28       Impact factor: 4.860

4.  Molecular genetics of hepatocellular neoplasia.

Authors:  Shilpa Jain; Shashideep Singhal; Peng Lee; Ruliang Xu
Journal:  Am J Transl Res       Date:  2010-01-23       Impact factor: 4.060

5.  Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma.

Authors:  Jorge García Martínez; Jhudit Pérez-Escuredo; Patricia Castro-Santos; César Alvarez Marcos; José Luis Llorente Pendás; Mario F Fraga; Mario A Hermsen
Journal:  Cell Oncol (Dordr)       Date:  2012-06-21       Impact factor: 6.730

Review 6.  Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.

Authors:  Igor P Pogribny; Ivan Rusyn; Frederick A Beland
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

Review 7.  DNA methylation in hepatocellular carcinoma.

Authors:  Iris Tischoff; Andrea Tannapfe
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 8.  Cocarcinogenic effects of alcohol in hepatocarcinogenesis.

Authors:  F Stickel; D Schuppan; E G Hahn; H K Seitz
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma.

Authors:  Vishnudutt Purohit; Rao Rapaka; Oh Sang Kwon; B J Song
Journal:  Life Sci       Date:  2012-10-30       Impact factor: 5.037

Review 10.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.